• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替唑硝唑抗登革病毒复制的活性。

Tizoxanide Antiviral Activity on Dengue Virus Replication.

机构信息

Department of Biochemistry, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.

Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27607, USA.

出版信息

Viruses. 2023 Mar 7;15(3):696. doi: 10.3390/v15030696.

DOI:10.3390/v15030696
PMID:36992406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10055917/
Abstract

Dengue virus is an important circulating arbovirus in Brazil responsible for high morbidity and mortality worldwide, representing a huge economic and social burden, in addition to affecting public health. In this study, the biological activity, toxicity, and antiviral activity against dengue virus type 2 (DENV-2) of tizoxanide (TIZ) was evaluated in Vero cell culture. TIZ has a broad spectrum of action in inhibiting different pathogens, including bacteria, protozoa, and viruses. Cells were infected for 1 h with DENV-2 and then treated for 24 h with different concentrations of the drug. The quantification of viral production indicated the antiviral activity of TIZ. The protein profiles in infected Vero cells treated and not treated with TIZ were analyzed using the label-free quantitative proteomic approach. TIZ was able to inhibit virus replication mainly intracellularly after DENV-2 penetration and before the complete replication of the viral genome. Additionally, the study of the protein profile of infected not-treated and infected-treated Vero cells showed that TIZ interferes with cellular processes such as intracellular trafficking and vesicle-mediated transport and post-translational modifications when added after infection. Our results also point to the activation of immune response genes that would eventually lead to a decrease of DENV-2 production. TIZ is a promising therapeutic molecule for the treatment of DENV-2 infections.

摘要

登革热病毒是巴西一种重要的循环虫媒病毒,在全球范围内可导致高发病率和死亡率,除了影响公共卫生外,还带来了巨大的经济和社会负担。在这项研究中,我们评估了替硝唑(TIZ)在 Vero 细胞培养物中的生物学活性、毒性和抗登革热病毒 2 型(DENV-2)活性。TIZ 在抑制包括细菌、原生动物和病毒在内的不同病原体方面具有广谱作用。用 DENV-2 感染细胞 1 小时,然后用不同浓度的药物处理 24 小时。病毒产量的定量表明了 TIZ 的抗病毒活性。用无标记定量蛋白质组学方法分析了用 TIZ 处理和未处理的感染 Vero 细胞的蛋白质图谱。TIZ 能够在 DENV-2 穿透后和病毒基因组完全复制之前主要在细胞内抑制病毒复制。此外,对未处理和感染后用 TIZ 处理的感染 Vero 细胞的蛋白质图谱的研究表明,TIZ 会干扰细胞内运输和囊泡介导的运输以及翻译后修饰等细胞过程,当在感染后加入时。我们的结果还表明,免疫反应基因被激活,最终导致 DENV-2 产量下降。TIZ 是治疗 DENV-2 感染的一种很有前途的治疗分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b9/10055917/c3fd04bb5a37/viruses-15-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b9/10055917/60c75d93d257/viruses-15-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b9/10055917/c3fd04bb5a37/viruses-15-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b9/10055917/60c75d93d257/viruses-15-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b9/10055917/c3fd04bb5a37/viruses-15-00696-g002.jpg

相似文献

1
Tizoxanide Antiviral Activity on Dengue Virus Replication.替唑硝唑抗登革病毒复制的活性。
Viruses. 2023 Mar 7;15(3):696. doi: 10.3390/v15030696.
2
Novel antiviral activity of baicalein against dengue virus.黄芩素抗登革热病毒的新抗病毒活性。
BMC Complement Altern Med. 2012 Nov 9;12:214. doi: 10.1186/1472-6882-12-214.
3
Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.具有抗登革热和日本脑炎病毒选择性抗病毒活性的核苷类似物。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00397-19. Print 2019 Jul.
4
Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.贯叶金丝桃素对感染登革热病毒 2 型的 BALB/c 小鼠的疗效。
Virol J. 2019 Feb 27;16(1):26. doi: 10.1186/s12985-019-1127-7.
5
Antiviral activity of four types of bioflavonoid against dengue virus type-2.四种类黄酮对登革热病毒 2 型的抗病毒活性。
Virol J. 2011 Dec 28;8:560. doi: 10.1186/1743-422X-8-560.
6
Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.从余甘子果皮中提取的 geraniin 与登革病毒 2 型包膜蛋白结合,并抑制病毒复制的早期阶段。
Virol J. 2017 Nov 21;14(1):229. doi: 10.1186/s12985-017-0895-1.
7
Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.蛹虫草素抑制登革热病毒感染的 Vero 细胞中的病毒复制。
Molecules. 2021 May 23;26(11):3118. doi: 10.3390/molecules26113118.
8
Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.UV-4B 与α干扰素联合方案抗登革病毒的抗病毒评估。
Viruses. 2021 Apr 27;13(5):771. doi: 10.3390/v13050771.
9
Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.天然生物碱茴香霉素抗登革热和寨卡病毒的抗病毒活性。
Antiviral Res. 2020 Apr;176:104749. doi: 10.1016/j.antiviral.2020.104749. Epub 2020 Feb 17.
10
Betulinic acid exhibits antiviral effects against dengue virus infection.桦木酸具有抗登革热病毒感染的抗病毒作用。
Antiviral Res. 2020 Dec;184:104954. doi: 10.1016/j.antiviral.2020.104954. Epub 2020 Oct 17.

引用本文的文献

1
Kelleni's protocol incorporating non-steroidal anti-inflammatory drugs and nitazoxanide to early manage dengue virus disease: An antiviral silver bullet.凯莱尼将非甾体抗炎药和硝唑尼特纳入其中的早期治疗登革病毒病方案:一种抗病毒的万灵药。
World J Clin Cases. 2025 Oct 6;13(28):108181. doi: 10.12998/wjcc.v13.i28.108181.
2
Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.在临床试验中靶向 NS2B-NS3 的正交黄病毒抑制剂,通过竞争性蛋白酶抑制的临床前体内疗效和细胞抗病毒活性。
Molecules. 2024 Aug 27;29(17):4047. doi: 10.3390/molecules29174047.

本文引用的文献

1
Dengue Vaccines: An Update.登革热疫苗:最新进展。
BioDrugs. 2022 May;36(3):325-336. doi: 10.1007/s40259-022-00531-z. Epub 2022 May 24.
2
A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.一种针对 NS3-NS4B 相互作用的泛血清型登革病毒抑制剂。
Nature. 2021 Oct;598(7881):504-509. doi: 10.1038/s41586-021-03990-6. Epub 2021 Oct 6.
3
In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2).体外抗登革病毒 2 型(DENV-2)的α-倒捻子素活性。
Molecules. 2021 May 19;26(10):3016. doi: 10.3390/molecules26103016.
4
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.早期使用硝唑尼特治疗轻度 COVID-19 疾病:随机、安慰剂对照试验。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.03725-2020. Print 2021 Jul.
5
Quantitative proteomic analysis of the tizoxanide effect in vero cells.替硝唑在 Vero 细胞中的作用的定量蛋白质组学分析。
Sci Rep. 2020 Sep 7;10(1):14733. doi: 10.1038/s41598-020-71634-2.
6
A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.一类新型登革热和西尼罗河病毒蛋白酶抑制剂,在报告基因 DENV-2 蛋白酶和病毒复制试验中具有亚微摩尔活性。
J Med Chem. 2020 Aug 13;63(15):8179-8197. doi: 10.1021/acs.jmedchem.0c00413. Epub 2020 Jul 15.
7
In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2.螺旋四内酯类化合物对登革病毒2型的体外抗病毒活性
J Gen Appl Microbiol. 2019 Sep 14;65(4):197-203. doi: 10.2323/jgam.2018.10.001. Epub 2019 Feb 28.
8
History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review.美巴两国登革热的历史、流行病学和诊断:综述。
Parasit Vectors. 2018 Apr 24;11(1):264. doi: 10.1186/s13071-018-2830-8.
9
Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.硝唑尼特抑制细胞培养中风疹病毒复制及其在原发性免疫缺陷患者中的应用。
Antiviral Res. 2017 Nov;147:58-66. doi: 10.1016/j.antiviral.2017.09.019. Epub 2017 Sep 30.
10
Dengue infection.登革热感染。
Nat Rev Dis Primers. 2016 Aug 18;2:16055. doi: 10.1038/nrdp.2016.55.